Home » Topics » BioWorld Science

BioWorld Science
RSS

Pharmacological profile of parenteral ET antagonist for SAH described by Roche

Jan. 14, 1998

Abgenix and Pfizer collaborate on XenoMouse antibodies

Jan. 14, 1998

Takeda obtains remaining HMR stake in French joint venture

Jan. 14, 1998

Agents with affinity for 5-HT2 receptors under development at Janssen

Jan. 14, 1998

Merck & Co. describes new thrombin inhibitors

Jan. 14, 1998

Novel ET antagonists claimed by BASF

Jan. 14, 1998

Serotonergic agents prepared at Merck KGaA as potential antidepressants/anxiolytics

Jan. 14, 1998

Vertex describes new IMPDH inhibitors

Jan. 14, 1998

Novartis discloses HIV protease inhibitors with excellent pharmacodynamic profile

Jan. 14, 1998

PDE IV/TNF production inhibitors claimed by Schering AG for MS

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...